COGT - Cogent Biosciences stock jumps on Phase 2 data for bezuclastinib
2024-02-22 15:01:15 ET
More on Cogent Biosciences
- Cogent Biosciences: Stock Soars On Cash Injection Ahead Of Major Data Catalyst
- Cogent Biosciences announces oversubscribed $225M private placement
- Citi starts Cogent Biosciences at buy, cites GI tumor drug potential
- Seeking Alpha’s Quant Rating on Cogent Biosciences
- Historical earnings data for Cogent Biosciences